Technology, Tracking & Visibility

Solo™ by Marken

Marken Solo™ was developed to provide our clients with a state-of-the-art system to manage all information and inventory for clinical trials throughout the life cycle. Marken Solo™ is a private inventory management system with just-in-time access to global stock levels. Marken Solo™supplies end-to-end control and visibility of all inventory maintained at the Clinical Supply Center, including investigational product, concomitant medication and all ancillary material.

Our Clinical Trial Inventory System, Solo, is a management system, supplying end-to-end control and visibility of your trial inventory.

Only Marken delivers the end-to-end capabilities and expert oversight needed to seamlessly guide your program through each stage of the pharmaceutical journey. Our experts and customer service specialists are available to discuss Marken Solo™, our Clinical Trial Inventory System. Contact us on +1-800-627-5361 (US) or email info@marken.com

Related resources

Supercharge Your Supply Chain: Harnessing AI to Gain Competitive Advantage

22 November 2023

Artificial Intelligence (AI) stands at the forefront of technological innovation, reshaping the specialty healthcare logistics landscape on a global scale….

Technological Innovations in Clinical Supply Chains: Maximizing End-to-End Visibility

17 October 2023

Technological advancements in personalized clinical supply chains are accelerating at a pace faster than ever before, and stakeholders are integrating…

Pioneering The Future Of Pharmaceutical Supply Chains Visibility, Technology and Innovative Medicine Modalities

17 October 2023

In response to ongoing global supply chain disruptors, key players in the pharmaceutical landscape are focusing on the enhancement of…

Happy Holidays from Marken

21 December 2022

At Marken, we are passionate about patients – always finding a way to deliver for our clients – on-time, within…

Decentralized Trials Call for Supply Chain Flexibility: Marken

8 April 2021

Outsourcing-Pharma and Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, Nina Vas, and Senior Director of Global…

Compelling Advantages of Creating a Patient-Centric Supply Chain

8 February 2021

Only a clinical trial supply chain partner that exhibits global regulatory and trade compliance proficiency and transports shipments in a…

View more
Marken Logo

Understanding why we must adapt, continuously asking ourselves how we can change what matters is how we keep on delivering it.